Glycopyrrolate/Formoterol Fumarate MDI Compared With Spiriva® as An Active Control in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Completed
Pearl Therapeutics, Inc.
Phase 2
2012-04-01
The primary objective of this study is to assess the efficacy of Glycopyrrolate/Formoterol
Fumarate MDI relative to individual components (GP MDI and FF MDI) in subjects with moderate
to severe COPD
Multi-Center Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD (PINNACLE 2)
Completed
Pearl Therapeutics, Inc.
Phase 3
2013-07-01
This is a multicenter, randomized, double-blind, parallel group, chronic-dosing (24 weeks),
placebo-controlled study to assess the efficacy and safety of Glycopyrrolate (GP and
Formoterol Fumarate (FF) combination metered-dose inhaler (MDI) (GFF; PT003), GP MDI (PT001),
and FF MDI (PT005) compared with Placebo MDI in subjects with moderate to very severe COPD.
Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate in Chronic Obstructive Pulmonary Disease
Completed
Chiesi Farmaceutici S.p.A.
Phase 3
2014-01-01
The purpose of this study is to determine the triple combination of beclometasone
dipropionate+Formoterol fumarate+Glycopyrrolate bromide is effective for the treatment of
severe COPD patients (chronic obstructive pulmonary disease)
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
